Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Endocrine
|
July 3, 2014
Mouse GDF9 decreases KITL gene expression in human granulosa cells
Astrud R Tuck, David G Mottershead, Herman A Fernandes, et al.
Journal of Cell Science
|
August 24, 2006
Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation
Robert B Gilchrist, Lesley J Ritter, Samu Myllymaa, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 16, 2004
Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells
Noora Kaivo-Oja, David G Mottershead, Sabine Mazerbourg, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 14, 2014
Modifications of human growth differentiation factor 9 to improve the generation of embryos from low competence oocytes
Jing-Jie Li, Satoshi Sugimura, Thomas D Mueller, et al.
Endocrinology
|
February 2, 2012
A covalently dimerized recombinant human bone morphogenetic protein-15 variant identifies bone morphogenetic protein receptor type 1B as a key cell surface receptor on ovarian granulosa cells
Minna M Pulkki, David G Mottershead, Arja H Pasternack, et al.
Journal of Assisted Reproduction and Genetics
|
January 5, 2022
Effect of cumulin and super-GDF9 in standard and biphasic mouse IVM
Nazli Akin, Dulama Richani, Xiuhua Liao, et al.
Molecular and Cellular Endocrinology
|
December 29, 2007
Characterization of recombinant human growth differentiation factor-9 signaling in ovarian granulosa cells
David G Mottershead, Minna M Pulkki, Pranuthi Muggalla, et al.
Molecular and Cellular Endocrinology
|
October 13, 2010
The bioactivity of human bone morphogenetic protein-15 is sensitive to C-terminal modification: characterization of the purified untagged processed mature region
Minna M Pulkki, Samu Myllymaa, Arja Pasternack, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 21, 2014
Aberrant GDF9 expression and activation are associated with common human ovarian disorders
Courtney M Simpson, David M Robertson, Sara L Al-Musawi, et al.
Reproduction (Cambridge, England)
|
March 31, 2005
Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function
Kenneth P McNatty, Jennifer L Juengel, Karen L Reader, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Endocrine
|
July 3, 2014
Mouse GDF9 decreases KITL gene expression in human granulosa cells
Astrud R Tuck, David G Mottershead, Herman A Fernandes, et al.
Journal of Cell Science
|
August 24, 2006
Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation
Robert B Gilchrist, Lesley J Ritter, Samu Myllymaa, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 16, 2004
Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells
Noora Kaivo-Oja, David G Mottershead, Sabine Mazerbourg, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 14, 2014
Modifications of human growth differentiation factor 9 to improve the generation of embryos from low competence oocytes
Jing-Jie Li, Satoshi Sugimura, Thomas D Mueller, et al.
Endocrinology
|
February 2, 2012
A covalently dimerized recombinant human bone morphogenetic protein-15 variant identifies bone morphogenetic protein receptor type 1B as a key cell surface receptor on ovarian granulosa cells
Minna M Pulkki, David G Mottershead, Arja H Pasternack, et al.
Journal of Assisted Reproduction and Genetics
|
January 5, 2022
Effect of cumulin and super-GDF9 in standard and biphasic mouse IVM
Nazli Akin, Dulama Richani, Xiuhua Liao, et al.
Molecular and Cellular Endocrinology
|
December 29, 2007
Characterization of recombinant human growth differentiation factor-9 signaling in ovarian granulosa cells
David G Mottershead, Minna M Pulkki, Pranuthi Muggalla, et al.
Molecular and Cellular Endocrinology
|
October 13, 2010
The bioactivity of human bone morphogenetic protein-15 is sensitive to C-terminal modification: characterization of the purified untagged processed mature region
Minna M Pulkki, Samu Myllymaa, Arja Pasternack, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 21, 2014
Aberrant GDF9 expression and activation are associated with common human ovarian disorders
Courtney M Simpson, David M Robertson, Sara L Al-Musawi, et al.
Reproduction (Cambridge, England)
|
March 31, 2005
Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function
Kenneth P McNatty, Jennifer L Juengel, Karen L Reader, et al.
Page
of 4